ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) FOR RECURRENT GLIOBLASTOMA

被引：0

作者：

MERCHANT, RE ^{[1
]}

MERCHANT, LH ^{[1
]}

YOUNG, HF ^{[1
]}

机构：

[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298

来源：

JOURNAL OF NEURO-ONCOLOGY | 1987年 / 5卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：177 / 177

页数：1

共 50 条

[1] TREATMENT OF RECURRENT GLIOBLASTOMA WITH LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2)
YOUNG, HF
MERCHANT, LH
COOK, SHS
MERCHANT, RE
NEUROSURGERY, 1988, 23 (02) : 261 - 261
[2] ALLOGENEIC LYMPHOKINE ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) REDUCE ESTABLISHED PULMONARY METASTASES
SHILONI, E
MULE, JJ
SCHWARZ, S
ROSENBERG, SA
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 362 - 362
[3] ADOPTIVE IMMUNOTHERAPY FOR RECURRENT GLIOBLASTOMA-MULTIFORME USING LYMPHOKINE ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2
MERCHANT, RE
GRANT, AJ
MERCHANT, LH
YOUNG, HF
CANCER, 1988, 62 (04) : 665 - 671
[4] ADOPTIVE IMMUNOTHERAPY OF MURINE HEPATIC METASTASES WITH LYMPHOKINE ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) CAN MEDIATE THE REGRESSION OF BOTH IMMUNOGENIC AND NONIMMUNOGENIC SARCOMAS AND AN ADENOCARCINOMA
LAFRENIERE, R
ROSENBERG, SA
JOURNAL OF IMMUNOLOGY, 1985, 135 (06): : 4273 - 4280
[5] REGIONAL ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR LIVER METASTASES
KEILHOLZ, U
SCHEIBENBOGEN, C
BRADO, M
GEORGI, P
MACLACHLAN, D
BRADO, B
HUNSTEIN, W
EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) : 103 - 105
[6] NATURAL-KILLER (NK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) ACTIVATED KILLER (LAK) CELLS IN CANCER-PATIENTS
CHING, N
KUBOTA, I
LOPEZ, M
ANCHETA, A
WONG, GK
CHING, C
JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 380 - 380
[7] ADMINISTRATION OF SLOWLY RELEASED RECOMBINANT INTERLEUKIN-2 - AUGMENTATION OF THE EFFICACY OF ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
NISHIMURA, T
UCHIYAMA, Y
YAGI, H
HASHIMOTO, Y
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 91 (01) : 21 - 27
[8] INTRALESIONAL INFUSION OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) FOR THE TREATMENT OF PATIENTS WITH MALIGNANT BRAIN-TUMOR
MERCHANT, RE
MERCHANT, LH
COOK, SHS
MCVICAR, DW
YOUNG, HF
NEUROSURGERY, 1988, 23 (06) : 725 - 732
[9] THE ADOPTIVE IMMUNOTHERAPY OF CANCER USING LYMPHOKINE ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2
ETTINGHAUSEN, SE
ROSENBERG, SA
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (01): : 51 - 71
[10] Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors
Sankhla, SK
Nadkarni, JS
Bhagwati, SN
JOURNAL OF NEURO-ONCOLOGY, 1996, 27 (02) : 133 - 140

← 1 2 3 4 5 →